Cargando…

A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA(14)-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice

Japanese encephalitis virus (JEV), a mosquito-borne flavivirus that causes fatal neurological disease in humans, is one of the most important emerging pathogens of public health significance. JEV represents the JE serogroup, which also includes West Nile, Murray Valley encephalitis, and St. Louis en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Sang-Im, Song, Byung-Hak, Kim, Jin-Kyoung, Yun, Gil-Nam, Lee, Eun-Young, Li, Long, Kuhn, Richard J., Rossmann, Michael G., Morrey, John D., Lee, Young-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117607/ https://www.ncbi.nlm.nih.gov/pubmed/25077483 http://dx.doi.org/10.1371/journal.ppat.1004290

Ejemplares similares

Correction: A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA(14)-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice
Publicado: (2014)

Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain
por: Yang, Jian, et al.
Publicado: (2017)

Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14
por: Huang, Rong, et al.
Publicado: (2019)

The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism
por: Liu, Xinyu, et al.
Publicado: (2018)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)

Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2
por: Li, Shi-Hua, et al.
Publicado: (2013)

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children
por: Kwon, Hyo Jin, et al.
Publicado: (2015)

Characteristics of Chimeric West Nile Virus Based on the Japanese Encephalitis Virus SA14-14-2 Backbone
por: Li, Guohua, et al.
Publicado: (2021)

Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus
por: Gupta, Paridhi, et al.
Publicado: (2017)

Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults
por: Khan, Siraj Ahmed, et al.
Publicado: (2016)

Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence
por: Phillips, Joanna J., et al.
Publicado: (2001)

Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
por: Upreti, Shyam Raj, et al.
Publicado: (2017)

An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia
por: Hills, Susan L., et al.
Publicado: (2022)

The Infection of the Japanese Encephalitis Virus SA14-14-2 Strain Induces Lethal Peripheral Inflammatory Responses in IFNAR Deficiency Mice
por: Liu, Juan, et al.
Publicado: (2022)

Molecular Determinants of Mouse Neurovirulence and Mosquito Infection for Western Equine Encephalitis Virus
por: Mossel, Eric C., et al.
Publicado: (2013)

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
por: Wijesinghe, Pushpa Ranjan, et al.
Publicado: (2016)

A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea
por: Kim, Dong Soo, et al.
Publicado: (2014)

Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area
por: Turtle, Lance, et al.
Publicado: (2017)

Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology
por: Rempel, Julia D., et al.
Publicado: (2004)

Immune responses and protective effects against Japanese encephalitis induced by a DNA vaccine encoding the prM/E proteins of the attenuated SA14-14-2 strain
por: Zheng, Xiaoyan, et al.
Publicado: (2020)

Japanese encephalitis: The virus and vaccines
por: Yun, Sang-Im, et al.
Publicado: (2014)

T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine
por: Wang, Ran, et al.
Publicado: (2020)

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2012)

Establishment of a mouse model to express bovine CD14 short hairpin RNA
por: Li, Xiangping, et al.
Publicado: (2015)

Characterization of nonstructural protein 3 of a neurovirulent Japanese encephalitis virus strain isolated from a pig
por: Deng, Xufang, et al.
Publicado: (2011)

Polyomavirus Wakes Up and Chooses Neurovirulence
por: Butic, Arrienne B., et al.
Publicado: (2023)

Cloning and Expression of Recombinant Tick-Borne Encephalitis Virus-like Particles in Pichia pastoris
por: Yun, Seok-Min, et al.
Publicado: (2014)

Glycosylation on envelope glycoprotein of duck Tembusu virus affects virus replication in vitro and contributes to the neurovirulence and pathogenicity in vivo
por: Liu, Dejian, et al.
Publicado: (2021)

Early Events in Japanese Encephalitis Virus Infection: Viral Entry
por: Yun, Sang-Im, et al.
Publicado: (2018)

Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain
por: Sarkar, Arindam, et al.
Publicado: (2013)

NEUROVIRULENCE AND PERSISTENCY OF MOUSE HEPATITIS VIRUSES IN RATS
por: Wege, H., et al.
Publicado: (1980)

A Novel Family of [1,4]Thiazino[2,3,4-ij]quinolin-4-ium Derivatives: Regioselective Synthesis Based on Unsaturated Heteroatom and Heterocyclic Compounds and Antibacterial Activity
por: Potapov, Vladimir A., et al.
Publicado: (2021)

Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial
por: Zaman, K., et al.
Publicado: (2022)

Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence
por: Fukui, Ayano, et al.
Publicado: (2023)

Profiling of Viral Proteins Expressed from the Genomic RNA of Japanese Encephalitis Virus Using a Panel of 15 Region-Specific Polyclonal Rabbit Antisera: Implications for Viral Gene Expression
por: Kim, Jin-Kyoung, et al.
Publicado: (2015)

Antibody escape by polyomavirus capsid mutation facilitates neurovirulence
por: Lauver, Matthew D, et al.
Publicado: (2020)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

The Mutation of the Genes Related to Neurovirulence in HSV-2 Produces an Attenuated Phenotype in Mice
por: Liu, Lei, et al.
Publicado: (2020)

High-resolution NMR structure of an RNA model system: the 14-mer cUUCGg tetraloop hairpin RNA
por: Nozinovic, Senada, et al.
Publicado: (2010)

IJS: An Intelligent Junction Selection Based Routing Protocol for VANET to Support ITS Services
por: Bhoi, Sourav Kumar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7lm5t8nvdrk7rcr7mcv79131lr